Hanseatic Management Services Inc Apellis Pharmaceuticals, Inc. Transaction History

Hanseatic Management Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $3,960 - $5,691	85 New	85 $6,000
Q3 2022 Nov 08, 2022	BUY	$44.76 - $69.66 $3,804 - $5,921	85 New	85 $6,000
Q3 2021 Oct 05, 2021	SELL	$31.4 - $69.84 $3,171 - $7,053	-101 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$40.9 - $64.9 $4,130 - $6,554	101 New	101 $6,000

300

111M

2.63M

845K

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.67B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.